Neurocrine Bioscience buy Barclays PLC
Start price
09.09.24
/
50%
€109.95
Target price
09.09.25
€144.91
Performance (%)
-1.86%
Price
19.09.24
€107.90
Summary
This prediction is currently active. With a performance of -1.86%, the BUY prediction for Neurocrine Bioscience by Barclays_PLC is down slightly. This prediction currently runs until 09.09.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Neurocrine Bioscience | -1.551% |
iShares Core DAX® | 2.291% |
iShares Nasdaq 100 | 1.336% |
iShares Nikkei 225® | 1.132% |
iShares S&P 500 | 1.272% |
Comments by Barclays_PLC for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target lowered by analysts at Barclays PLC from $180.00 to $160.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Barclays_PLC for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€139.00
02.08.24
02.08.24
€164.74
02.08.25
02.08.25
-22.37%
19.09.24
19.09.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€131.25
02.05.24
02.05.24
€157.54
02.05.25
02.05.25
-17.79%
19.09.24
19.09.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€129.15
23.01.24
23.01.24
€137.96
23.01.25
23.01.25
-16.45%
19.09.24
19.09.24